See also
ˇ Show More
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Merck & Co. Inc., Common-Size Consolidated Income Statement
| Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | Dec 31, 2006 | ||
|---|---|---|---|---|---|---|
 |
Sales | |
|
|
|
|
|
Materials and production | |
|
|
|
|
|
Marketing and administrative | |
|
|
|
|
|
Research and development | |
|
|
|
|
|
Restructuring costs | |
|
|
|
|
|
U.S. Vioxx Settlement Agreement charge | |
|
|
|
|
|
Operating income | % |
% |
% |
% |
% |
|
Equity income from affiliates | |
|
|
|
|
|
Interest income | |
|
|
|
|
|
Interest expense | |
|
|
|
|
|
Exchange gains (losses) | |
|
|
|
|
|
Other, net | |
|
|
|
|
|
Other income (expense), net | % |
% |
% |
% |
% |
|
Income before taxes | % |
% |
% |
% |
% |
|
Taxes on income | |
|
|
|
|
|
Net income | % |
% |
% |
% |
% |
|
Net income attributable to noncontrolling interests | |
|
|
|
|
|
Net income attributable to Merck & Co., Inc. | % |
% |
% |
% |
% |
February 8, 2012